http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104610168-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104610168-B |
| titleOfInvention | Cyclohexane barbituric acid chirality spiro-compound as well as preparation method and application thereof |
| abstract | The invention discloses a cyclohexane barbituric acid chirality spiro-compound indicated in formula I (shown in description) or acceptable salt, hydrate or solvate of the compound in crystal form and pharmacy. R1 and R2 are selected from aryl or substituent aryl respectively or simultaneously; R3, R4 and R5 are selected from hydrogen, C1-C6 alkyl or C1-C6 alkoxy respectively or simultaneously. The novel compound shown in the formula I has restraining effect on one or more kinds of Escherichia coli, xanthomonas maltophilia, Ruofei acinetobacter, staphylocccus aureus and staphylococcus epidermidis, and provides novel choice for screening antiseptic, bacteriostatic and germicidal medicine in clinic practice. |
| priorityDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.